##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



---

FORM 10-QSB



---

(Mark One)

|x | QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ---------------------------------------------------------------------------------

For the quarterly period ended: September 30, 2007



| ̈ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
|- | ---------------------------------------------------------------

For the transition period from  to

Commission File Number: 000-52029



---

PLATINUM RESEARCH ORGANIZATION, INC.

(Exact name of small business issuer as specified in its charter)



---



|                                                               |  |                                  
|-------------------------------------------------------------- |  | ---------------------------------
|Delaware                                                       |  | 20-2842514                       
|(State or other jurisdiction of incorporation or organization) |  | (IRS Employer Identification No.)



|                                                |  |           
|----------------------------------------------- |  | ----------
|2777 Stemmons Freeway, Suite 1440, Dallas Texas |  | 75207     
|(Address of principal executive offices)        |  | (Zip code)

Issuers telephone number: (214) 271-9503



---

Check whether the issuer (1) filed all
reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.    Yes  x    No ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ̈No  x

State the number of shares outstanding of each of the issuers classes of common equity, as of the latest practicable date:

75,000,000 shares of common stock issued and outstanding as of November 9, 2007

Transitional Small Business
Disclosure Format (Check one):    Yes ̈No  x



---



---

##### Table of Contents

TABLE OF CONTENTS



|                                           |  |                                                                                                             |  |         
|------------------------------------------ |  | ----------------------------------------------------------------------------------------------------------- |  | --------
|                                           |  |                                                                                                             |  | Page No.
|NOTE REGARDING FORWARD-LOOKING INFORMATION |  | 1                                                                                                          
|                                           | 
|PART I: FINANCIAL INFORMATION              |  | 1                                                                                                          
|                                           |  |                                                                                                            
|                                           |  | Item 1. Financial Statements (unaudited)                                                                    |  | 1       
|                                           |  |                                                                                                            
|                                           |  | Consolidated Balance Sheets as of September 30, 2007 and December 31, 2006                                  |  | 2       
|                                           |  |                                                                                                            
|                                           |  | Consolidated Statement of Operations for the Three and Nine -Month Periods Ended September 30,2007 and 2006 |  | 3       
|                                           |  |                                                                                                            
|                                           |  | Consolidated Statement of Cash Flows for the Nine-Month Periods Ended September 30, 2007 and 2006           |  | 4       
|                                           |  |                                                                                                            
|                                           |  | Consolidated Statement of Changes in Shareholders Equity                                                   |  | 5       
|                                           |  |                                                                                                            
|                                           |  | Notes to Consolidated Financial Statements                                                                  |  | 6       
|                                           |  |                                                                                                            
|                                           |  | Item 2. Managements Discussion and Analysis or Plan of Operation                                           |  | 15      
|                                           |  |                                                                                                            
|                                           |  | Item 3. Controls and Procedures                                                                             |  | 18      
|                                           | 
|PART II: OTHER INFORMATION                 |  | 19                                                                                                         
|                                           |  |                                                                                                            
|                                           |  | Item 6. Exhibits                                                                                            |  | 19      
|                                           | 
|SIGNATURES                                 |  | 20                                                                                                         
|                                           | 
|EXHIBIT INDEX                              |  | 21                                                                                                         



---

##### Table of Contents

NOTE CONCERNING FORWARD-LOOKING INFORMATION

The statements contained in this Form 10-QSB that are not purely
historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These include statements about our expectations, beliefs, intentions or
strategies for the future, which are indicated by words or phrases such as anticipate, expect, intend, plan, will, believe, management believes and similar words or
phrases. The forward-looking statements are based on our current expectations and are subject to certain risks, uncertainties and assumptions. Our actual results could differ materially from results anticipated in these forward-looking statements.
All forward-looking statements included in this document are based on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements.

PART IFINANCIAL INFORMATION



|Item 1. | Financial Statements
|------- | --------------------

The interim financial
statements included herein are unaudited but reflect, in managements opinion, all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation of financial position and the results of our operations for the
interim periods presented.

The interim financial statements should be read in conjunction with the financial statements of Platinum
Research Organization, Inc. (the Company) and the notes thereto contained in the Companys audited financial statements for the year ended December 31, 2006 presented in the Annual Report on Form 10-KSB that was filed with the
Securities and Exchange Commission (the SEC) on March 23, 2007.

Interim results are not necessarily indicative of results
for the full fiscal year.



1



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Consolidated Balance Sheet

U.S. Dollars

(Unaudited)



|                                                              |  |              |           |              |   |           |  
|------------------------------------------------------------- |  | ------------ | --------- | ------------ | - | --------- | -
|                                                              |  | Sep 30, 2007 |           | Dec 31, 2006 |  
|Assets                                                        |  |              |           |              |   |           |  
|Current Assets                                                |  |              |           |              |   |           |  
|Cash  unrestricted                                           |  | $            | 2,395,623 |              | $ | 211,778   |  
|Cash-Restricted                                               |  |              | 1,585,598 |              |   | 1,527,389 |  
|                                                              |  |              |           |              |   |           |  
|Total Cash                                                    |  |              | 3,981,221 |              |   | 1,739,167 |  
|Accounts Receivable                                           |  |              | 3,738     |              |   | 3,301     |  
|                                                              |  |              |           |              |   |           |  
|Total Current Assets                                          |  |              | 3,984,959 |              |   | 1,742,468 |  
|                                                              |  |             
|Property, Plant and Equipmentnet of accumulated depreciation |  |              | 77,364    |              |   | 1,402     |  
|                                                              |  |             
|Other Assets                                                  |  |              |           |              |   |           |  
|Loan Issuance CostsNet of accumulated amortization           |  |              | 199,237   |              |   | 327,254   |  
|Intellectual PropertyNet of accumulated amortization         |  |              | 3,538,566 |              |   | 3,698,207 |  
|Intellectual Propertynon amortizable                         |  |              | 193,843   |              |   | 133,490   |  
|                                                              |  |              |           |              |   |           |  
|Total Other Assets                                            |  |              | 3,931,646 |              |   | 4,158,951 |  
|                                                              |  |             
|Total Assets                                                  |  | $            | 7,993,969 |              | $ | 5,902,821 |  
|                                                              |  |              |           |              |   |           |  
|                                                              |  |             
|Liabilities and Shareholders Equity                          |  |              |           |              |   |           |  
|Current Liabilities                                           |  |              |           |              |   |           |  
|Accounts Payable                                              |  | $            | 83,070    |              | $ | 134,187   |  
|Accrued Interest                                              |  |              | 70,000    |              |   | 70,000    |  
|Preferred Dividend Payable                                    |  |              | 206,199   |              |   |          |  
|                                                              |  |              |           |              |   |           |  
|Total Current Liabilities                                     |  |              | 359,269   |              |   | 204,187   |  
|                                                              |  |             
|Long Term Debt                                                |  |              | 6,000,000 |              |   | 6,000,000 |  
|                                                              |  |             
|Shareholders Equity                                          |  |              | 1,634,700 |              |   | (301,366  | )
|                                                              |  |              |           |              |   |           |  
|Total Liabilities and Shareholders Equity                    |  | $            | 7,993,969 |              | $ | 5,902,821 |  
|                                                              |  |              |           |              |   |           |  

The accompanying notes are an integral part of these financial statements.



2



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Consolidated Statement of Operations

U.S. Dollars

(Unaudited)



|                                                                       |  |                    |             |   |         |   |            |                   |  |   |            |   |  |                          |            |   |              |   |            |                         |  |   |            |   |  |   |            |  
|---------------------------------------------------------------------- |  | ------------------ | ----------- | - | ------- | - | ---------- | ----------------- |  | - | ---------- | - |  | ------------------------ | ---------- | - | ------------ | - | ---------- | ----------------------- |  | - | ---------- | - |  | - | ---------- | -
|                                                                       |  | Three Months Ended |             |   |         |   |            | Nine Months Ended |  |   |            |   |  | For the Period From Date |           
|                                                                       |  | 9/30/07            |             |   | 9/30/06 |   |            | Incr/ (Decr)      |  |   | 9/30/07    |   |  | 9/30/06                  |            |   | Incr/ (Decr) |   |            | of Inception to 9/30/07 | 
|Sales                                                                  |  |                    |            |   |         |   |           |                   |  |   |           |   |  |                          |           |   |              |   |           |                         |  |   |           |   |  |   |           |  
|Cost of Goods Sold                                                     |  |                    |            |   |         |   |           |                   |  |   |           |   |  |                          |           |   |              |   |           |                         |  |   |           |   |  |   |           |  
|Gross Profit                                                           |  |                    |            |   |         |   |           |                   |  |   |           |   |  |                          |           |   |              |   |           |                         |  |   |           |   |  |   |           |  
|                                                                       |  |                    |             |   |         |   |           
|Selling General and Administrative Expenses                            |  |                    |             |   |         |   |            |                   |  |   |            |   |  |                          |            |   |              |   |            |                         |  |   |            |   |  |   |            |  
|                                                                       |  |                    |             |   |         |   |           
|Salaries                                                               |  |                    | 191,609     |   |         |   | 73,132     |                   |  |   | 118,477    |   |  |                          | 466,653    |   |              |   | 218,685    |                         |  |   | 247,968    |   |  |   | 1,263,124  |  
|Travel                                                                 |  |                    | 17,547      |   |         |   | 18,328     |                   |  |   | (781       | ) |  |                          | 86,787     |   |              |   | 68,932     |                         |  |   | 17,855     |   |  |   | 310,452    |  
|Product Evaluation / Technical Support                                 |  |                    | 156,570     |   |         |   | 31,375     |                   |  |   | 125,195    |   |  |                          | 265,546    |   |              |   | 104,125    |                         |  |   | 161,421    |   |  |   | 653,472    |  
|Outside Legal and Professional Fees                                    |  |                    | 250,921     |   |         |   | 89,163     |                   |  |   | 161,758    |   |  |                          | 777,042    |   |              |   | 233,458    |                         |  |   | 543,584    |   |  |   | 1,707,007  |  
|Contribution Agreement Related Costs                                   |  |                    |            |   |         |   |           |                   |  |   |           |   |  |                          | 339,783    |   |              |   |           |                         |  |   | 339,783    |   |  |   | 339,783    |  
|Insurance                                                              |  |                    | 18,806      |   |         |   | 12,696     |                   |  |   | 6,110      |   |  |                          | 96,842     |   |              |   | 38,291     |                         |  |   | 58,551     |   |  |   | 264,872    |  
|Rent                                                                   |  |                    | 6,081       |   |         |   | 6,503      |                   |  |   | (422       | ) |  |                          | 29,364     |   |              |   | 17,342     |                         |  |   | 12,022     |   |  |   | 101,789    |  
|Other                                                                  |  |                    | 41,229      |   |         |   | 5,156      |                   |  |   | 36,073     |   |  |                          | 77,549     |   |              |   | 18,849     |                         |  |   | 58,700     |   |  |   | 169,332    |  
|                                                                       |  |                    |             |   |         |   |            |                   |  |   |            |   |  |                          |            |   |              |   |            |                         |  |   |            |   |  |   |            |  
|Total SG&A                                                             |  |                    | 682,763     |   |         |   | 236,353    |                   |  |   | 446,410    |   |  |                          | 2,139,566  |   |              |   | 699,682    |                         |  |   | 1,439,884  |   |  |   | 4,809,831  |  
|                                                                       |  |                    |             |   |         |   |           
|Depreciation and Amortization                                          |  |                    | 84,065      |   |         |   | 122,231    |                   |  |   | (38,166    | ) |  |                          | 329,420    |   |              |   | 365,671    |                         |  |   | (36,251    | ) |  |   | 1,540,474  |  
|                                                                       |  |                    |             |   |         |   |           
|Other Income                                                           |  |                    | 62,046      |   |         |   | 27,998     |                   |  |   | 34,048     |   |  |                          | 150,076    |   |              |   | 99,791     |                         |  |   | 50,285     |   |  |   | 416,618    |  
|Interest Expense                                                       |  |                    | 210,000     |   |         |   | 210,000    |                   |  |   |           |   |  |                          | 654,794    |   |              |   | 630,000    |                         |  |   | 24,794     |   |  |   | 2,880,528  |  
|                                                                       |  |                    |             |   |         |   |            |                   |  |   |            |   |  |                          |            |   |              |   |            |                         |  |   |            |   |  |   |            |  
|Net Loss Before Taxes                                                  |  |                    | (914,782    | ) |         |   | (540,586   | )                 |  |   | (374,196   | ) |  |                          | (2,973,704 | ) |              |   | (1,595,562 | )                       |  |   | (1,378,142 | ) |  |   | (8,814,215 | )
|                                                                       |  |                    |             |   |         |   |           
|Income TaxCurrent                                                     |  |                    |            |   |         |   |           |                   |  |   |           |   |  |                          |           |   |              |   |           |                         |  |   |           |   |  |   |           |  
|Income TaxDeferred                                                    |  |                    |            |   |         |   |           |                   |  |   |           |   |  |                          |           |   |              |   |           |                         |  |   |           |   |  |   |           |  
|                                                                       |  |                    |             |   |         |   |           
|Net Loss                                                               |  |                    | (914,782    | ) |         |   | (540,586   | )                 |  |   | (374,196   | ) |  |                          | (2,973,704 | ) |              |   | (1,595,562 | )                       |  |   | (1,378,142 | ) |  |   | (8,814,215 | )
|                                                                       |  |                    |             |   |         |   |           
|Loss per Common ShareBasic                                            |  | $                  | (0.01       | ) |         | $ | (0.02      | )                 |  | $ | (0.01      | ) |  | $                        | (0.04      | ) |              | $ | 0.05       |                         |  | $ | (0.01      | ) |  | $ | (0.25      | )
|                                                                       |  |                    |             |   |         |   |           
|Weighted Average Number of Shares used in per share calculationsBasic |  |                    | 102,500,000 |   |         |   | 32,500,000 |                   |  |   | 70,000,000 |   |  |                          | 77,335,165 |   |              |   | 29,239,927 |                         |  |   | 48,095,238 |   |  |   | 36,684,000 |  

The accompanying notes are an integral part of these financial statements.



3



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Consolidated Statement of Cash Flows

U.S. Dollars

(Unaudited)



|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|-------------------------------------------------------------------- |  | ----------------------- | ---------- | - | ------------ | - | ---------- | --------- |  | - | ---------- | -
|                                                                     |  | Nine-Month Period Ended |            |   | Inception to |  
|                                                                     |  | 9/30/2007               |            |   | 9/30/2006    |   |            | 9/30/2007 | 
|Cash Flow From Operating Activities                                  |  |                         |            |   |              |   |            |           |  |   |            |  
|Net Loss for the Period                                              |  | $                       | (2,973,704 | ) |              | $ | (1,595,562 | )         |  | $ | (8,814,215 | )
|Items not requiring Cash                                             |  |                         |            |   |              |   |            |           |  |   |            |  
|Depreciation and Amortization                                        |  |                         | 329,420    |   |              |   | 365,671    |           |  |   | 1,540,474  |  
|Option Expense                                                       |  |                         | 115,438    |   |              |   |           |           |  |   | 115,438    |  
|Changes in Assets and Liabilities                                    |  |                         |            |   |              |   |            |           |  |   |            |  
|(Increase) / Decrease in Receivables                                 |  |                         | 94         |   |              |   | (937       | )         |  |   | (3,207     | )
|Increase / (Decrease) in Payables                                    |  |                         | (51,116    | ) |              |   | (4,049     | )         |  |   | 83,071     |  
|Increase / (Decrease) in Accrued Interest                            |  |                         |           |   |              |   |           |           |  |   | 1,167,681  |  
|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|Net Cash Used in Operating Activities                                |  |                         | (2,579,868 | ) |              |   | (1,234,877 | )         |  |   | (5,910,758 | )
|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|Cash Flow From Investing Activities                                  |  |                         |            |   |              |   |            |           |  |   |            |  
|Purchases of Property, Plant and Equipment                           |  |                         | (77,655    | ) |              |   | (715       | )         |  |   | (80,628    | )
|Investment in Intellectual Property                                  |  |                         | (100,423   | ) |              |   | (68,075    | )         |  |   | (347,052   | )
|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|Net Cash Used in Investing Activities                                |  |                         | (178,078   | ) |              |   | (68,790    | )         |  |   | (427,680   | )
|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|Cash Flow From Financing Activities                                  |  |                         |            |   |              |   |            |           |  |   |            |  
|Net ProceedsLong Term Debt                                          |  |                         |           |   |              |   |           |           |  |   | 5,550,000  |  
|Preferred Shares Issued for Cash                                     |  |                         | 4,500,000  |   |              |   |           |           |  |   | 4,500,000  |  
|Funds Received From Previously Controlled Entity                     |  |                         | 500,000    |   |              |   |           |           |  |   | 500,000    |  
|Loan Costs/Other                                                     |  |                         |           |   |              |   | (9,879     | )         |  |   | (230,341   | )
|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|Net Cash Generated From Financing Activities                         |  |                         | 5,000,000  |   |              |   | (9,879     | )         |  |   | 10,319,659 |  
|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|Increase (decrease) in cash and cash equivalents                     |  |                         | 2,242,054  |   |              |   | (1,313,546 | )         |  |   | 3,981,221  |  
|Cash and Cash Equivalents Beginning of Period                        |  |                         | 1,739,167  |   |              |   | 3,553,211  |           |  |   |           |  
|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|Cash and Cash Equivalents End of Period                              |  | $                       | 3,981,221  |   |              | $ | 2,239,665  |           |  | $ | 3,981,221  |  
|                                                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|                                                                     |  |                         |           
|Supplemental Disclosures:                                            |  |                         |            |   |              |   |            |           |  |   |            |  
|Cash Paid During the Period for:                                     |  |                         |            |   |              |   |            |           |  |   |            |  
|Interest                                                             |  | $                       | 654,794    |   |              | $ | 630,000    |           |  | $ | 2,880,528  |  
|Income Tax                                                           |  |                         |           |   |              |   |           |           |  |   |           |  
|                                                                     |  |                         |           
|Non-Cash Items                                                       |  |                         |            |   |              |   |            |           |  |   |            |  
|Purchase of Intellectual Property Through the Assumption of Debt     |  |                         |           |   |              |   |           |           |  | $ | 4,475,789  |  
|Partners Capital Contribution Resulting from the Forgiveness of Debt |  |                         |           |   |              |   |           |           |  | $ | 5,536,597  |  
|Preferred Dividends                                                  |  | $                       | 206,200    |   |              |   |           |           |  | $ | 206,200    |  
|Loan Costs Neted Against Proceeds of Loan                            |  |                         |           |   |              |   |           |           |  | $ | 450,000    |  

The accompanying notes are an integral part of these financial statements.



4



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Consolidated Statement of Changes in Shareholders Equity

U.S.
Dollars

(Unaudited)



|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|---------------------------------------------------------- |  | --------------------------- | - |  | --------------------------- |  | ----------------------- |  | --------------- | - |  | ----------------- |  | --------------------------------- | - |  | ----------------------- | - |  | ---------- |  | ------------------- | - |  | --------------------- | -
|                                                           |  | Number Common Shares Issued |   |  | NumberPreferredSharesIssued |  | Number ofWarrantsIssued |  | Capital Stock $ |   |  | Preferred Stock $ |  | Paid inCapital andDistributions $ |   |  | Subscriptions Payable $ |   |  | Warrants $ |  | DeficitAccumulated$ |   |  | Shareholders Equity $ |  
|Balance at April 28, 2004  Date of Inception              |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Forgiveness of Debt (Note 11)                              |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 5,536,597                         |   |  |                         |   |  |            |  |                     |   |  | 5,536,597             |  
|Capital Contributions                                      |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 4,484                             |   |  |                         |   |  |            |  |                     |   |  | 4,484                 |  
|Distributions                                              |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | (145                              | ) |  |                         |   |  |            |  |                     |   |  | (145                  | )
|Net Loss                                                   |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  | (1,347,794          | ) |  | (1,347,794            | )
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Balance at December 31, 2004                               |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 5,540,936                         |   |  |                         |   |  |            |  | (1,347,794          | ) |  | 4,193,142             |  
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Capital Contributions                                      |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 1,938                             |   |  |                         |   |  |            |  |                     |   |  | 1,938                 |  
|Distributions                                              |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | (4,740                            | ) |  |                         |   |  |            |  |                     |   |  | (4,740                | )
|Net Loss                                                   |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  | (2,147,610          | ) |  | (2,147,610            | )
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Balance at December 31, 2005                               |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 5,538,134                         |   |  |                         |   |  |            |  | (3,495,404          | ) |  | 2,042,730             |  
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Capital Contributions                                      |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 1,086                             |   |  |                         |   |  |            |  |                     |   |  | 1,086                 |  
|Distributions                                              |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | (75                               | ) |  |                         |   |  |            |  |                     |   |  | (75                   | )
|Earnings Charge for options expense (Note 5)               |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Net Loss for period                                        |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  | (2,345,107          | ) |  | (2,345,107            | )
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Balance at December 31, 2006                               |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 5,539,145                         |   |  |                         |   |  |            |  | (5,840,511          | ) |  | (301,366              | )
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Capital Contributions                                      |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 268                               |   |  |                         |   |  |            |  |                     |   |  | 268                   |  
|Earnings Charge for options expense (Note 5)               |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 36,359                            |   |  |                         |   |  |            |  |                     |   |  | 36,359                |  
|Net Loss for period                                        |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  | (817,684            | ) |  | (817,684              | )
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Balance at March 31, 2007                                  |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 5,575,772                         |   |  |                         |   |  |            |  | (6,658,195          | ) |  | (1,082,423            | )
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Capital contributions cash                                 |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 269                               |   |  |                         |   |  |            |  |                     |   |  | 269                   |  
|Shares Issued to PRO Transferors (Note 5)                  |  | 55,000,000                  |   |  |                             |  |                         |  | 55,000          |   |  |                   |  | (55,000                           | ) |  |                         |   |  |            |  |                     |   |  |                       |  
|Preferred Equity raised (Note 5)                           |  |                             |   |  | 5,000,000                   |  |                         |  |                 |   |  | 5,000             |  | 4,495,000                         |   |  |                         |   |  |            |  |                     |   |  | 4,500,000             |  
|Warrants Issued to Investa/Pineda (Note 5)                 |  |                             |   |  |                             |  | 2,500,000               |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Earnings charge for options expense (Note 6)               |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 45,053                            |   |  |                         |   |  |            |  |                     |   |  | 45,053                |  
|Preferred dividends payable (Note 5)                       |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  | (93,700                 | ) |  |            |  |                     |   |  | (93,700               | )
|Net Loss for Period                                        |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  | (1,241,238          | ) |  | (1,241,238            | )
|Equity of PRO Inc. at 3/31/2007                            |  | 42,500,000                  |   |  |                             |  |                         |  | 42,500          |   |  |                   |  | 435,097                           |   |  |                         |   |  |            |  |                     |   |  | 477,597               |  
|Change in PRO Inc. Equity 3/31-4/18/2007 (Note 5)          |  | (22,500,000                 | ) |  |                             |  |                         |  | (22,500         | ) |  |                   |  | 44,904                            |   |  |                         |   |  |            |  |                     |   |  | 22,404                |  
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Equity of PRO Inc. time of contribution agreement (Note 1) |  | 20,000,000                  |   |  |                             |  |                         |  | 20,000          |   |  |                   |  | 480,001                           |   |  |                         |   |  |            |  |                     |   |  | 500,001               |  
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Balance at June 30, 2007                                   |  | 75,000,000                  |   |  | 5,000,000                   |  | 2,500,000               |  | 75,000          |   |  | 5,000             |  | 10,541,095                        |   |  | (93,700                 | ) |  |            |  | (7,899,433          | ) |  | 2,627,962             |  
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Capital Contributions                                      |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | (6                                | ) |  |                         |   |  |            |  |                     |   |  | (6                    | )
|Preferred Dividend payable (Note 5)                        |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  | (112,500                | ) |  |            |  |                     |   |  | (112,500              | )
|Earnings charge for options expense (Note 6)               |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  | 34,026                            |   |  |                         |   |  |            |  |                     |   |  | 34,026                |  
|Net Loss for period                                        |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  | (914,782            | ) |  | (914,782              | )
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  
|Balance at September 30, 2007                              |  | 75,000,000                  |   |  | 5,000,000                   |  | 2,500,000               |  | 75,000          |   |  | 5,000             |  | 10,575,115                        |   |  | (206,200                | ) |  |            |  | (8,814,215          | ) |  | 1,634,700             |  
|                                                           |  |                             |   |  |                             |  |                         |  |                 |   |  |                   |  |                                   |   |  |                         |   |  |            |  |                     |   |  |                       |  

The accompanying notes are an integral part of these financial statements.



5



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial Statements

September 30, 2007

---



|1. | Nature and Continuance of Operations
|-- | ------------------------------------

The Company
was incorporated in the State of Nevada on May 13, 2005, under the name NorthTech Corporation. The Company was originally formed to develop, expand and market two web-based database programs for small business and community sports.
The Company completed its initial public offering in March 2006, and subsequently abandoned its software development business. On April 13, 2007, the Company completed a merger with its wholly-owned subsidiary Platinum Research Organization,
Inc. to reincorporate the Company in Delaware, and the name of the surviving Company became Platinum Research Organization, Inc. We acquired Platinum Research Organization L.P., a Texas limited partnership (Platinum LP),
pursuant to a Contribution Agreement we entered into on October 26, 2006, and Platinum LP became a wholly-owned subsidiary of the Company effective April 18, 2007 (Note 7). The Company no longer pursues software development, and the sole
focus of our business is the development, manufacture and marketing of high-performance lubricants and coatings products.

As noted above,
we acquired Platinum LP effective April 18, 2007. The transaction has been accounted for as a reverse acquisition application of the purchase method of accounting by the Company (formerly known as NorthTech), with Platinum LP treated as the
accounting acquirer. Accordingly, the assets and liabilities of the Company (formerly known as NorthTech) have been recorded at their respective historical costs, and added to those of Platinum LP, and the reported results of operations of the
Company will reflect historical results of operations of Platinum LP.

The closing of
the Contribution Agreement resulted in our acquisition of Platinum LP and the appointment of a new slate of directors. As a result of our acquisition of Platinum LP, the Companys new business focus is the design, development and
commercialization of patented high-performance lubricants and coatings. The Companys products will be marketed under the trade name TechroBond for automotive, aviation, industrial and consumer aftermarkets. TechroBondTMis one of a series of product applications Platinum LP developed based on its patented processes and technologies relating to a fluorinated thiophosphate and
a new technique to react zinc dialkyl dithiophosphate (ZDDP) and poly tetra fluroethylene to yield new proprietary compounds that enhance the anti-wear and extreme pressure capabilities of lubricants and coatings (individually and
collectively, the PRO Technology). The resulting compounds have yielded significantly enhanced anti-wear and extreme pressure capabilities when measured in bench laboratory tests at the University of Texas at Arlington, and, more
importantly, suggest that the PRO Technology may be a replacement for ZDDP in engine and lubricating oils. Management believes that this new technology will position the Company to penetrate several large, global markets for lubricants should the
Company be successful in bringing its products that rely upon this new technology to market.

The Company is a development stage
enterprise, as defined in Statements of Financial Accounting Standards (SFAS) No. 7. The Company is currently devoting all of its present efforts to commercialization of its products and technologies. Accordingly, no revenue has
been realized to date.

The Companys financial statements at September 30, 2007 and for the three- and nine-month periods then
ended have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company incurred a loss of $2,973,704 for the nine -month period
ended September 30, 2007 and had cash of $3,981,221 at September 30, 2007.

Management cannot provide assurance that the Company will
ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital. Management believes that the Companys capital resources should be adequate to continue operating and maintaining its
business strategy for the next seven to eight months. However, if the Company is unable to realize revenue from the



6



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial
Statements

September 30, 2007

---



commercialization of its products or is unable to raise additional capital in the future, management expects that the Company will need to seek additional
capital on less favorable terms and/or pursue other remedial measures. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might
be necessary should the Company be unable to continue as a going concern.



|2. | Significant Accounting Policies
|-- | -------------------------------

The following is a
summary of significant accounting policies used in the preparation of these financial statements.

Basis of presentation

The accompanying unaudited interim financial statements have been prepared as of September 30, 2007, and for the three and nine month periods ended
September 30, 2007 and 2006 in accordance with accounting principles generally accepted in the United States of America (GAAP) relating to the preparation of financial statements for interim periods. Accordingly, they do not include all
the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair
presentation have been included. Operating results for the three and nine-month periods ended September 30, 2007 are not necessarily indicative of the results that may be expected for the year ending December 31, 2007.

These interim financial statements follow the same accounting policies and methods of their application as the most recent annual financial statements.
These interim financial statements should be read in conjunction with the audited financial statements of the Company as at December 31, 2006, as contained in the Companys Form 10-KSB filed with the Securities and Exchange Commission on
March 23, 2007.

Principles of consolidation

The consolidated financial statements include the accounts of PRO, Inc., PRO, LP and PIP, LP., its wholly owned subsidiaries. All material intercompany accounts and transactions are eliminated in consolidation.

Cash and cash equivalents

Cash and cash equivalents include highly liquid investments with original maturities of three months or less.

Financial
instruments

The carrying value of cash, loans receivable, accounts payable and accrued liabilities, amounts due to related parties and
convertible promissory notes payable approximates their fair value because of the short maturity of these instruments. Prior to April 2007, the Companys operations were located in Canada, and virtually all of its assets and liabilities gave
rise to significant exposure to market risks from changes in foreign currency rates. The Companys financial risk was the risk that arose from fluctuations in foreign exchange rates and the degree of volatility of these rates. Subsequent to
March 2007, the Companys operations are located in the United States and foreign currency transactions are not prevalent. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk.



7



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial
Statements

September 30, 2007

---



Derivative financial instruments

The Company has not, to the date of these financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.

Income taxes

Deferred income taxes
are reported for timing differences between items of income or expense reported in the financial statements and those reported for income tax purposes in accordance with SFAS No. 109, Accounting for Income Taxes, which requires the use
of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and
liabilities and their respective tax bases, and for tax loss and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences
are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not. As of September 30, 2007
and September 30, 2006, the net deferred tax asset has been offset by a valuation allowance.

Basic and diluted net loss per share

The Company computes net loss per share in accordance with SFAS No. 128, Earnings per Share. SFAS No. 128 requires
presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares
outstanding (denominator) during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing
diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all potentially dilutive shares if their effect is
anti-dilutive.

Comprehensive loss

SFAS No. 130, Reporting Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As of September 30, 2007, the
Company had no items that represented a comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements.

Segments of an enterprise and related information

SFAS No. 131, Disclosures about Segments
of an Enterprise and Related Information, supersedes SFAS No. 14, Financial Reporting for Segments of a Business Enterprise. SFAS 131 establishes standards for the way that public companies report information about operating segments
in annual financial statements and requires reporting of selected information about operating segments in interim financial statements issued to the public. It also establishes standards for disclosures regarding products and services, geographic
areas and major customers. SFAS 131 defines operating segments as components of a company about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources
and in assessing performance. The Company has evaluated this SFAS and does not believe it is applicable at this time.

Start-up expenses

The Company has adopted Statement of Position No. 98-5, Reporting the Costs of Start-up Activities, which
requires that costs associated with start-up activities be expensed as incurred. Accordingly, start-up costs associated with the Companys formation have been included in the Companys expenses for the period from the date of incorporation
on May 13, 2005 to September 30, 2007.



8



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial
Statements

September 30, 2007

---



Foreign currency translation

The Companys functional and reporting currency is in U.S. dollars. The financial statements of the Company are translated to U.S. dollars in accordance with SFAS No. 52, Foreign Currency Translation.
Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Gains and losses arising on translation or settlement of foreign currency denominated transactions or
balances are included in the determination of income. The Company has not, to the date of these financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.

Use of estimates

The preparation of
financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates.

Recent
accounting pronouncements

In February 2007, the Financial Accounting Standards Board (the FASB) issued SFAS No. 159,
The Fair Value Option for Financial Assets and Financial Liabilities (SFAS 159). SFAS 159 allows the Company to choose to measure many financial assets and financial liabilities at fair value. Unrealized gains and losses on
items for which the fair value option has been elected are reported in earnings. SFAS 159 is effective for fiscal years beginning after November 15, 2007. After reviewing SFAS 159 and 157, the company has elected not to measure financial assets
and liabilities at fair value.

In September 2006, the FASB issued SFAS No. 157, Fair Value Measurement (SFAS
157). The Statement provides guidance for using fair value to measure assets and liabilities. The Statement also expands disclosures about the extent to which companies measure assets and liabilities at fair value, the information used to
measure fair value, and the effect of fair value measurement on earnings. This Statement applies under other accounting pronouncements that require or permit fair value measurements. This Statement does not expand the use of fair value measurements
in any new circumstances. Under this Statement, fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the entity transacts.
SFAS 157 is effective for the Company for fair value measurements and disclosures made by the Company in its fiscal year beginning on January 1, 2008. After reviewing SFAS 159 and 157, the company has elected not to measure financial assets and
liabilities at fair value.

In February 2006, the FASB issued SFAS No. 155, Accounting for Certain Hybrid Financial
Instruments, which amends SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities and SFAS No. 140. SFAS No. 155 permits fair value measurement for any hybrid financial instrument that
contains an embedded derivative that otherwise would require bifurcation, establishes a requirement to evaluate interests in securitized financial assets to identify interests that are freestanding derivatives or hybrid financial instruments
containing embedded derivatives. The adoption of SFAS No. 155 is not expected to have a material impact on the Companys financial position, results of operations or cash flows.

In July 2006, the FASB issued FASB interpretation No. 48, Accounting for Uncertainty in Income Taxes, an Interpretation of FASB Statement
No. 109 (FIN 48). FIN 48 provides guidance on the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FIN 48 requires



9



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial
Statements

September 30, 2007

---



that we recognize in the financial statements the impact of a tax position if that position more likely than not will be sustained on an audit, based on the
technical merits of the position. FIN 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transition provisions. The transition adjustment recognized on the date of
adoption is recorded as an adjustment to retained earnings as of the beginning of the adoption period. After reviewing FASB 48, the company does not believe that adoption of FASB 48 will have a material impact on the companys financial
statements.

Comparative figures

Certain comparative figures have been adjusted to conform to the current periods presentation.



|3. | Accounts Payable and Accrued Liabilities
|-- | ----------------------------------------

Accounts
payable and accrued liabilities are non-interest bearing, unsecured and have settlement dates within one year.



|4. | Long Term Debt
|-- | --------------

As of September 30, 2007, the
Company had $6,000,000 in long term debt due under a note with the Seattle City Employees Retirement System (SCERS). The principal amount outstanding under this note bears interest at a fixed rate equal to 14% per annum, which will
increase to 19% per annum following any event of default under the note. Accrued interest on the outstanding principal is payable on a quarterly basis, and all outstanding principal and interest is due and payable on February 28, 2011. As
additional consideration for making the loan, SCERS will receive quarterly participation payments at the end of each fiscal quarter that are equal to the greater of (i) 5% of the Companys gross revenues on a consolidated basis, or
(ii) 20% of the Companys consolidated net income, for such quarter. The participation payments will continue until SCERS is paid all of the principal and accrued interest under the note, plus an aggregate $6.0 million in participation
payments. SCERS has received no participation payments through the quarter ended September 30, 2007. The note is secured by all of the assets of the Company.



|5. | Capital Stock
|-- | -------------

Authorized

As of September 30, 2007, the Companys total authorized capital was 400,000,000 common shares, with a par value of $0.001 per common share, and
100,000,000 preferred shares, with a par value of $0.001 per preferred share.

In contemplation of the completion of the Contribution
Agreement (see Note 7), a total of 5,000,000 authorized preferred shares were designated as Series A Preferred Stock (the Series A Preferred Stock), which are convertible into common shares of the Company at a rate of five
common shares for each share of Series A Preferred Stock at any time by the holder or by the Company under certain conditions. The Series A Preferred Stock is also subject to mandatory conversion on the last day of any period of twenty consecutive
trading days ending on or after the sale of the underlying shares of common stock are registered with the Securities and Exchange Commission in which the volume weighted average of the daily market price of the Companys common stock equals or
exceeds 200% of the adjusted conversion price of the Series A Preferred Stock.



10



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial
Statements

September 30, 2007

---



The terms of the Series A Preferred Stock entitle the holder to annual cumulative dividends of $0.09 per share, payable
quarterly at the discretion of the Companys Board of Directors. The annual cumulative dividend will be reduced to $0.045 per share upon the Company entering into a commercial agreement(s) that increases the Companys aggregate revenues to
$40,000,000 per annum and to an annual $0.018 per share upon the Company recording net revenues equal to or greater than $1,000,000 per quarter.

The Series A Preferred Stock has a maturity date of five years from the date of closing of the Contribution Agreement (see Note7).

Issued and outstanding

Under the terms of the Contribution Agreement (please see Note 7 below), on April 18, 2007, the
Company:



| | a) | issued to the Pro Transferors, 55,000,000 unregistered shares of Company common stock;
| | -- | --------------------------------------------------------------------------------------



| | b) | issued to the Investors 5,000,000 shares of Series A Preferred Stock;
| | -- | ---------------------------------------------------------------------



| | c) | issued to Investa Corporation and Ms. Pineda 2,500,000 warrants to purchase shares of common stock at a price of $0.26 per share; and
| | -- | -------------------------------------------------------------------------------------------------------------------------------------



| | d) | cancelled 22,500,000 shares of Company common stock held by Ms. Pineda.
| | -- | -----------------------------------------------------------------------

As of September 30, 2007, the Companys total issued and outstanding capital stock consisted of 75,000,000 common shares, 5,000,000 shares of Series A Preferred Stock and warrants to acquire 2,500,000 common
shares.

On February 8, 2007, the Company issued 10,000,000 common shares valued at a price of $0.05 per share upon the exercise of
previously outstanding share purchase warrants issued March 30, 2006. As of September 30, 2007, no share purchase warrants in this series were outstanding.

On March 30, 2006, 10,000,000 Units (the Units) of the Company were issued for cash proceeds of $100,000. Each Unit consisted of one common share of the Company and one fifth of one purchase warrant
share. Each full purchase warrant share entitled the holder to purchase an additional five common shares of the Company at a price of $0.25 per common share expiring March 30, 2009.

Warrants

The following is a summary
of warrant activities during the nine-month period ended September 30, 2007:



|                                                  |  |                    |   |  |                                 |     
|------------------------------------------------- |  | ------------------ | - |  | ------------------------------- | ----
|                                                  |  | Number of warrants |   |  | Weighted average exercise price
|Outstanding and exercisable at December 31, 2006  |  | 2,000,000          |   |  | $                               | 0.25
|Exercised                                         |  | (2,000,000         | ) |  | $                               | 0.25
|                                                  |  |                    |   |  |                                 |     
|Outstanding and exercisable at March 31, 2007     |  |                   |   |  |                                 |    
|                                                  |  |                    |   |  |                                 |     
|Granted                                           |  | 2,500,000          |   |  | $                               | 0.26
|                                                  |  |                    |   |  |                                 |     
|Outstanding and exercisable at June 30, 2007      |  | 2,500,000          |   |  | $                               | 0.26
|                                                  |  |                    |   |  |                                 |     
|Outstanding and exercisable at September 30, 2007 |  | 2,500,000          |   |  | $                               | 0.26
|                                                  |  |                    |   |  |                                 |     



11



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial
Statements

September 30, 2007

---



|6. | Equity
|-- | ------

Effective January 1, 2006, the Company
adopted SFAS No. 123R Share Based Payment under the modified prospective method described therein. Compensation expense recognized in the three- and nine-month periods ended September 30, 2006 and 2007 includes compensation
expense for all stock-based payments granted, modified or vested since adoption of SFAS No. 123R based on the grant date fair value. Stock-based compensation expense recognized in the three- and nine-month periods ended September 30, 2007
was included in Selling, General and Administrative Expenses and totaled $34,026 and $115,438 respectively. No stock-based compensation was recognized in the three- and nine -month periods ended September 30, 2006.

Prior to the consummation of the transactions contemplated by the Contribution Agreement (see Note 7), Platinum LP had issued to key executive officers
and consultants, options to acquire up to 18.685% of limited partner partnership interests in Platinum LP. Following the completion of the transactions contemplated in the Contribution Agreement (see Note 7), the Company issued options to acquire
23,292,184 shares of common stock to holders of the Platinum LP options, in substitution for, and following the cancellation of, the Platinum LP options. The substitution of the Company options for the Platinum LP options complied with Sections 409A
and 424 of the Internal Revenue Code of 1986, as amended, and the Treasury Regulations proposed and issued thereunder. Accordingly, and in addition to the satisfaction of other requirements under these provisions, the ratio of the exercise price to
the fair market value of the shares subject to the Company options issued in substitution of the Platinum LP options immediately following the consummation of the transactions contemplated by the Contribution Agreement was not greater than the ratio
of the exercise price to the fair market value of the canceled Platinum LP options immediately prior to the transaction. Additionally, the excess of the fair market value of the Company options issued in substitution of the Platinum LP options over
their respective strike prices did not exceed the fair market value of the Platinum options over their respective strike prices. The fair market value of the Platinum LP options was established by an independent appraisal completed in August 2007.

On August 3, 2007, the independent members of the Companys Board of Directors met and approved a proposal to cancel all of the
outstanding employee stock options held by the Companys Chief Financial Officer, Michael D. Newman, which were granted on April 18, 2007 at an exercise price of $1.35, and reissue 3,116,428 options at an exercise price of $0.78, which was
the closing per share market price of the common stock on August 3, 2007.



|7. | Contribution Agreement
|-- | ----------------------

On October 26, 2006,
the Company entered into a contribution agreement (the Contribution Agreement) with Platinum LP, Lubrication Partners, joint venture (GP Transferor) and sole shareholder of Platinum IP Management, Inc., the general partner of
Platinum LP (PRO GP), each holding a limited partnership interest in Platinum LP (each, a Limited Partner and collectively, the PRO Transferors) and John T. (Cork) Jaeger as the representative of all PRO
Transferors (the PRO Transferor Representative), and Steve Drayton as the representative (the Investor Representative) of all certain individuals who invested in the Company (other than the PRO Transferors) (the
Investors) in a private placement completed in conjunction with the Contribution Agreement.



12



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial
Statements

September 30, 2007

---



Under the terms of the Contribution Agreement, GP Transferor contributed to the Company all of the capital stock of PRO GP,
each Limited Partner contributed to the Company all of the outstanding limited partner partnership interests of Platinum LP, and the Investors contributed to the Company an aggregate minimum cash amount of $4,500,000.

At the Companys Special Meeting held on April 12, 2007, stockholders approved the completion of the proposed Contribution Agreement transaction
with Platinum Research Organization, L.P. et al. The closing of the Contribution Agreement transaction became effective April 18, 2007.

Upon completion of the Contribution Agreement, the Company completed the following:



| | a) | Issued to the PRO Transferors 55,000,000 unregistered shares of common stock of the Company;
| | -- | --------------------------------------------------------------------------------------------



| | b) | Issued to the Investors 5,000,000 shares Series A Preferred Stock and 2,500,000 share purchase warrants (the Warrants). The Warrants were issued to the Investors on the
closing date. Each Warrant is exercisable for one common share of the Company at an exercise price of $0.26 per share for a three-year period from date of closing; and
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | c) | Entered into a bridge loan agreement (the Loan Agreement) with Platinum LP, pursuant to which the Company loaned Platinum LP $1,000,000 (the Platinum LP
Note). The Platinum LP Note bore regular interest at an annual rate of 10% per annum, was due and payable six months from the date of issuance, and was secured by a second lien on all of the assets of Platinum LP. On January 17,
2007, the Company advanced $1,000,000 to Platinum LP under the terms of the Loan Agreement. The Loan Agreement was satisfied on the April 18, 2007 closing date upon the conversion of the promissory note evidencing the loan into shares of Series
A Preferred Stock.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

During the second quarter, the Company entered into an amending agreement whereby the Company assumed
certain general security obligations upon closing of the Contribution Agreement.



|8. | Commitments
|-- | -----------

On June 20, 2007, the Company
signed a five-year lease for new office space at a rate of approximately $60,000 per year, effective September 1, 2007 (see Note 9). The Company had previously leased office space from EFO Holdings, a related party to Lubrication Partners, L.P.
and Lubrication Joint Venture, our two largest stockholders.

On July 3, 2007, the Company entered into a $60,000 standby letter of
credit agreement with Crescent Real Estate Funding VIII LP as a condition of an office lease, also with Crescent Real Estate Funding VIII LP, entered into on June 20, 2007.



|9. | Subsequent Events
|-- | -----------------

On October 12, 2007, the
Compensation Committee of the Board of Directors of the Company approved Short-Term and Long-Term Incentive Plans for the Chief Executive Officer and the Senior Vice President & Chief Financial Officer of the Company. The material terms of
such plans are described in the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on October 16, 2007.



13



---

##### Table of Contents

Platinum Research Organization, Inc. and Subsidiaries

(A Development Stage Company)

Notes to Consolidated Financial
Statements

September 30, 2007

---



|10. | Earnings Per Share
|--- | ------------------

Basic earnings per share are
computed by dividing net earnings less dividends on Series A Preferred Stock by the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed similarly to basic earnings per share, except the
denominator is increased by including the number of additional common shares that would have been outstanding if dilutive potential common shares had been issued. This calculation is not done for periods in a loss position as this would be
antidilutive.



|                                             |  |                    |   |  |                   |   |  |                   |   |  |                   |   |  |                                                 |  
|-------------------------------------------- |  | ------------------ | - |  | ----------------- | - |  | ----------------- | - |  | ----------------- | - |  | ----------------------------------------------- | -
|                                             |  | Three Months Ended |   |  | Nine Months Ended |   |  |                   |  
|                                             |  | September 30,2007  |   |  | September 30,2006 |   |  | September 30,2007 |   |  | September 30,2006 |   |  | For the Period from Date of Inception to9/30/07 |  
|Numerator                                    |  |                    |   |  |                   |   |  |                   |   |  |                   |   |  |                                                 |  
|Net Income (Loss)                            |  | (914,782           | ) |  | (540,586          | ) |  | (2,973,704        | ) |  | (1,595,562        | ) |  | (8,814,215                                      | )
|Dividends Declared on Preferred Stock        |  | (112,500           | ) |  |                  |   |  | (206,200          | ) |  |                  |   |  | (206,200                                        | )
|                                             |  |                    |   |  |                   |   |  |                   |   |  |                   |   |  |                                                 |  
|Net Loss Attributable to Common Shareholders |  | (1,027,282         | ) |  | (540,586          | ) |  | (3,179,904        | ) |  | (1,595,562        | ) |  | (9,020,415                                      | )
|                                             |  |                    |   |  |                  
|Denominator                                  |  |                    |   |  |                   |   |  |                   |   |  |                   |   |  |                                                 |  
|Basic Weighted Average Shares Outstanding    |  | 102,500,000        |   |  | 32,500,000        |   |  | 77,335,165        |   |  | 29,239,927        |   |  | 36,684,000                                      |  
|                                             |  |                    |   |  |                  
|Basic Earnings per Share                     |  | (0.01              | ) |  | (0.02             | ) |  | (0.04             | ) |  | (0.05             | ) |  | (0.25                                           | )



|11. | Debt Forgiveness
|--- | ----------------

In April 2004, $5,536,597 of debt
owed by Platinum LP to Lubrication Partners JV was forgiven in exchange for 100% equity interest in Platinum LP.



14



---

##### Table of Contents

|Item 2. | Managements Discussion and Analysis or Plan of Operation.
|------- | ----------------------------------------------------------

All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, business strategy, budgets, projected costs and plans and objectives of
management for future operations, are considered to be forward-looking statements. We express our expectations, beliefs and projections in good faith and believe our expectations reflected in these forward-looking statements are based on reasonable
assumptions; however, we cannot assure you that these expectations, beliefs or projections will prove to have been correct.

Readers are
referred to the caption Risk Factors appearing at the end of Item 1 of our latest Annual Report on Form 10-KSB for additional factors that may affect our forward-looking statements. In light of these risks, uncertainties and
assumptions, the forward-looking events discussed in this report might not occur. We undertake no obligation to update or revise our forward-looking statements, whether as a result of new information, future events or otherwise.

Overview

The Company was incorporated in the State
of Nevada on May 13, 2005, under the name NorthTech Corporation. The Company was originally formed to develop, expand and market two web-based database programs for small business and community sports. The Company completed its
initial public offering in March 2006, and subsequently abandoned its software development business. On April 13, 2007, the Company completed a merger with its wholly-owned subsidiary Platinum Research Organization, Inc. to reincorporate the
Company in Delaware, and the name of the surviving Company became Platinum Research Organization, Inc. We acquired Platinum LP, pursuant to a Contribution Agreement we entered into on October 26, 2006, and it became a wholly-owned
subsidiary of the Company effective April 18, 2007. The Company no longer pursues software development, and the sole focus of our business is the development, manufacture and marketing of high-performance lubricants and coatings products.

On April 18, 2007, we closed the Contribution Agreement, which resulted in our
acquisition of Platinum LP and the appointment of a new slate of directors. As a result of our acquisition of Platinum LP, the Companys new business focus is the design, development and commercialization of patented high-performance lubricants
and coatings. The Companys products will be marketed under the trade name TechroBond for automotive, aviation, industrial and consumer aftermarkets. TechroBondTMis one of a series of product applications Platinum LP developed based on its patented processes and technologies relating to a fluorinated thiophosphate and a new technique to react zinc dialkyl dithiophosphate
(ZDDP) and poly tetra fluroethylene to yield new proprietary compounds that enhance the anti-wear and extreme pressure capabilities of lubricants and coatings (individually and collectively, the PRO Technology). The resulting
compounds have yielded significantly enhanced anti-wear and extreme pressure capabilities when measured in bench laboratory tests at the University of Texas at Arlington, and, more importantly, suggest that the PRO Technology may be a replacement
for ZDDP in engine and lubricating oils. Management believes that this new technology will position the Company to penetrate several large, global markets for lubricants should the Company be successful in bringing its products that rely upon this
new technology to market.

The Companys intellectual property, including its patents, licenses and trademarks, is an important
component of its business. The Company actively protects its inventions, new technologies and product developments by filing patent applications or maintaining trade secrets. The Companys research and development efforts have resulted in
proprietary formulations and processes protected by five issued U.S. patents, four U.S. patent applications pending, five U.S. continuation-in-part applications and several trade secrets. The Company has filed these patents or patent applications in
key jurisdictions in the international market, and the U.S. patent applications are protected under PCT filings. These proprietary formulations and processes use specific chemical compounds that can act as a catalyst, a reactant or both to provide
surface and substrate modification in both liquid and solid lubricants to wear surfaces such as iron, steel and aluminum.

The Company
intends to develop three primary product lines within the lubricant additive industry, including greases, industrial oils and engine oils, as well as to develop specialty coatings. A more detailed description of the new business of the Company,
associated risk factors, and historical financial statements of Platinum LP are in the Definitive Schedule 14A Proxy Statement filed with the SEC on April 2, 2007.



15



---

##### Table of Contents

On July 31, 2007 the Company signed a global marketing and
distribution agreement with R.T. Vanderbilt, a manufacturer and distributor of chemicals and minerals serving a diverse set of markets worldwide. The agreement gives R.T. Vanderbilt the exclusive right to market and distribute the companys
TechroBondTMproducts on a global basis to the grease market.

Results of Operations

Three Months Ended September 30, 2007 Compared to Three Months Ended September 30, 2006.

Net Sales and Gross Profit. Net sales and gross profit for both the three-month period ended September 30, 2007 and the three-month period
ended September 30, 2006 was $0. The Company is a development stage company and continues to focus its efforts on the marketing and commercialization of the Companys products and technologies, the registration of its products with the
Environmental Protection Agency (the EPA), in Europe, Japan and the Far East and on further developing its relationships with key business partners in the Engine Oil, Grease, Industrial Oil and Coatings markets.

Selling, General and Administrative Expenses.The Companys total SG&A expenses for the three-month period ended September 30, 2007 were $682,763 an
increase of $446,410 over total SG&A expenses of $236,353 for the three-month period ended September 30, 2006. Total SG&A expenses are composed of outside legal and professional fees, salaries, insurance costs, product evaluation and
technical support and other SG&A expenses.

The Companys outside legal and professional fees for the three-month period ended
September 30, 2007 were $250,921, an increase of $161,758 over outside legal and professional fees of $89,163 for the three-month period ended September 30, 2006. This increase was due to increased product and technology consultancy costs;
increased public and investor relations costs and increased public company compliance costs associated with SEC filings and preferred stock registration statements.

The Companys salaries expense for the three-month period ended September 30, 2007 was $191,609 an increase of $118,477 over salaries expense of $73,132 for the three-month period ended September 30,
2006. This increase was primarily due to non-cash expenses incurred relating to the expensing of stock options pursuant to SFAS 123R, the addition of a new Chief Financial Officer following consummation of the Contribution Agreement and the
execution of a new employment contract for the Companys Chief Executive Officer.

The Companys insurance costs for the
three-month period ended September 30, 2007 were $18,806 an increase of $6,110 over insurance costs of $12,696 for the three-month period ended September 30, 2006. This increase was principally due principally to higher insurance costs
associated with patents and intellectual property.

Product evaluation and technical support expenses for the three-month period ended
September 30, 2007 were $156,570 an increase of $125,195 over product evaluation and technical support expenses of $31,375 for the three-month period ended September 30, 2006. This increase was due to an increase in scope of the testing
and research efforts conducted at the University of TexasArlington related to the Companys products and technologies and costs associated with registering the companys products in foreign countries.

Other SG&A expenses for the three-month period ended September 30, 2007 were $41,229, an increase of $36,073 over other SG&A expenses of
$5,156 for the three-month period ended September 30, 2006. This increase was due to increased office support costs and Board of Director related costs.

Depreciation and Amortization.Depreciation for the three-month period ended September 30, 2007 was $84,065, a decrease of $38,166 over depreciation of $122,231 for the three-month period ended September 30, 2006 and relates
principally to the amortization of loan issuance costs for debt with the City of Seattle, the amortization of capitalized patent expenses and the depreciation of office and testing equipment.



16



---

##### Table of Contents

Interest Expense.Interest expense for the three-month period ended September 30, 2007 was $210,000 which was flat
compared to interest expense of $210,000 for the three-month period ended September 30, 2006. Interest expense is primarily driven by long term debt of $6,000,000 with the City of Seattle Retirement system.

Other Income. Other income for the three-month period ended September 30, 2007 was $62,046 an increase of $34,048 over other income of $27,998 for the
three-month period ended September 30, 2006. This increase was due primarily to interest income from increased cash on hand as a result of equity raised through the Companys issuance, in April 2007, of the Series A Preferred Stock and the
issuance of warrants to acquire 2,500,000 shares of common stock.

Nine Months Ended September 30, 2007 Compared to Nine Months Ended
September 30, 2006

Net Sales and Gross Profit.Net sales and gross profit for both the nine-month period ending September 30, 2007
and the nine-month period ending September 30, 2006 was $0. The Company continues to focus its efforts on the marketing and commercialization of the Companys products and technologies, the registration of its products with the EPA, in
Europe, Japan and the Far East and efforts to further develop its relationships with key business partners in the Engine Oil, Grease, Industrial Oil and Coatings markets.

Selling, General and Administrative Expenses.The Companys total SG&A expenses for the nine-month period ended September 30, 2007 were $2,139,566, an increase of $1,439,884 over total SG&A
expenses of $699,682 for the nine-month period ended September 30, 2006. Total SG&A expenses are composed of outside legal and professional fees, salaries, insurance costs, product evaluation and technical support and other SG&A
expenses.

The Companys outside legal and professional fees for the nine-month period ended September 30, 2007 were $777,042 an
increase of $543,584 over outside legal and professional fees of $233,458 for the nine-month period ended September 30, 2006. This increase was due to legal and professional costs incurred in connection with the Companys issuance of the
Series A Convertible Preferred Stock and the issuance of warrants to acquire 2,500,000 shares of common stock; increased public company compliance costs associated with SEC filings; recruitment costs associated with hiring a new Chief Financial
Officer; increased product and technology consultancy costs and increased public and investor relations costs.

The Company incurred
$339,783 in costs related to the Contribution Agreement for the nine-month period ended September 30, 2007. No such costs were incurred during the same period in 2006. These costs consisted of outside legal, accounting and audit work related to
the Contribution Agreement and related transactions.

The Companys salaries expense for the nine-month period ended
September 30, 2007 was $466,653, an increase of $247,968 over salaries expense of $218,685 for the nine-month period ended September 30, 2006. This increase was primarily due to non-cash expenses incurred relating to the expensing of stock
options pursuant to SFAS 123R, the addition of a new Chief Financial Officer following consummation of the Contribution Agreement and the execution of a new employment contract for the Companys Chief Executive Officer.

The Companys insurance costs for the nine-month period ended September 30, 2007 were $96,842, an increase of $58,551 over insurance costs of
$38,291 for the nine-month period ended September 30, 2006. This increase was due to the purchase of a new Directors and Officers Liability Policy and higher costs associated with patents and intellectual property.

Product evaluation and technical support expenses for the nine-month period ended September 30, 2007 were $265,546, an increase of $161,421 over
product evaluation and technical support expenses of $104,125 for the nine-month period ended September 30, 2006. This increase was due to an increase in scope of the testing and research efforts conducted at the University of
TexasArlington related to the Companys products and technologies and costs associated with registering the companys products in foreign countries.

Other SG&A expenses for the nine-month period ended September 30, 2007 were $77,549, an increase of $58,700 over other SG&A expenses of $18,849 for the nine-month period ended September 30, 2006.
This increase was due mainly to increased office support costs and Board of Director related expenses.



17



---

##### Table of Contents

Depreciation and Amortization.Depreciation for the nine -month period ended September 30, 2007 was $329,420,
a decrease of $36,251 from depreciation of $365,671 for the nine-month period ended September 30, 2006 and relates to the amortization of loan issuance costs for debt with the SCERS, the amortization of capitalized patent expenses and the
depreciation of office and testing equipment.

Interest Expense.Interest expense for the nine -month period ended September 30, 2007 was $654,794,
an increase of $24,794 over interest expense of $630,000 for the nine-month period ended September 30, 2006, due mainly to additional interest costs associated with $1,000,000 in convertible promissory notes.

Other Income. Other income for the nine -month period ended September 30, 2007 was $150,076, an increase of $50,285 over other income of $99,791 for the
nine-month period ended September 30, 2006. This increase was due primarily to interest income from increased cash on hand as a result of equity raised through the Companys issuance of the Series A Preferred Stock and the issuance of
warrants to acquire 2,500,000 shares of common stock April 2007.

Liquidity and Capital Resources

As of September 30, 2007, the Company had total cash on hand of $3,981,221, of which $1,585,598 was restricted cash.

Cash flows used in operating activities for the nine months of September 30, 2007 were $2,579,868 compared to $1,234,877 used in operating
activities for the nine-month period ended September 30, 2006.

Net cash provided by financing activities was $5,000,000 for the first
nine months of 2007, consisting primarily of the private placement of 5,000,000 shares of Series A Preferred Stock for a purchase price of $4,500,000 (Note 5).

Management believes that the Companys capital resources are adequate to continue operating and maintaining its current business strategy during the next seven to eight months. While management is currently
seeking third party financing it can give no assurances that they will be successful in these efforts.

Critical Accounting Policies and Significant
Judgments and Estimates

There have been no material changes in our critical accounting policies or critical accounting estimates
since the filing of our initial registration statement on Form SB-2 in January 2006, nor have we adopted any accounting policy that has or will have a material impact on our consolidated financial statements. For further discussion of our accounting
policies see Note 2, Significant Accounting Policies in the Notes to Financial Statements in this Quarterly Report on Form 10-QSB and the Notes to Consolidated Financial Statements in our Annual Report on Form 10-KSB for the fiscal year
ended December 31, 2006.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements with any party.



|Item 3. | Controls and Procedures
|------- | -----------------------

Evaluation of Disclosure Controls
and Procedures

Our CEO and CFO have evaluated the effectiveness of our disclosure controls and procedures pursuant to Exchange Act
Rule 13a-15(b) as of the end of the period covered by this report. Our disclosure controls and procedures are designed to ensure that information that is required to be included in our filings with the SEC is recorded, processed, summarized and
reported within the time periods specified by the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Based on that
evaluation, they have concluded that our current disclosure controls and procedures are effective.



18



---

##### Table of Contents

Changes in Internal Control over Financial Reporting

There was no change in the Companys internal control over financial reporting during the quarterly period ended September 30, 2007 that has
materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting.

PART IIOTHER INFORMATION



|Item 6. | Exhibits.
|------- | ---------

A list of the exhibits required by Item 601 of
Regulation S-B and filed as part of this report is set forth in the Index to Exhibits on page 21, which immediately precedes such exhibits.



19



---

##### Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to the
signed on its behalf by the undersigned, thereunto duly authorized.



|                       |  |                                      |  |                                                                        
|---------------------- |  | ------------------------------------ |  | -----------------------------------------------------------------------
|                       |  | PLATINUM RESEARCH ORGANIZATION, INC.
|                       |  |                                     
|Date: November 9, 2007 |  | By:                                  |  | /s/ John T. Jaeger, Jr.                                                
|                       |  |                                      |  | John T. Jaeger, Jr.                                                    
|                       |  |                                      |  | President, Chief Executive Officer and Member of the Board of Directors
|                       |  |                                     
|Date: November 9, 2007 |  | By:                                  |  | /s/ Michael D. Newman                                                  
|                       |  |                                      |  | Michael D. Newman                                                      
|                       |  |                                      |  | Chief Financial Officer and Senior Vice President                      



20



---

##### Table of Contents

EXHIBIT INDEX



|            |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
|----------- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Exhibit No. |  | Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
|2.1         |  | Contribution Agreement, dated October 26, 2006, by and among Platinum Research Organization, LP, Lubrication Partners, joint venture, Platinum IP Management, Inc., John T. (Cork) Jaeger as the
representative of the partners of Platinum Research Organization, LP, and Steve Drayton as the representative of all certain individuals who invested in the Company in a private placement completed in conjunction with the Contribution Agreement
(incorporated by reference to Exhibit 2.1 filed with the Companys Current Report on Form 8-K/A-1 dated October 26, 2006).
|            | 
|2.2         |  | Amendment to Contribution Agreement dated December 26, 2006. (incorporated by reference to Exhibit 4.1 filed with the Companys Current Report on Form 8-K dated January 9,
2007).                                                                                                                                                                                                                                                                                                                                                                                              
|            | 
|2.3         |  | Amendment to Contribution Agreement dated February 28, 2007. (incorporated by reference to Exhibit 4.1 filed with the Companys Current Report on Form 8-K dated February 28,
2007).                                                                                                                                                                                                                                                                                                                                                                                            
|            | 
|3.1         |  | Certificate of Incorporation of Platinum Research Organization, Inc. (filed as Exhibit A to the Companys Proxy Statement filed with the Securities and Exchange Commission on April 2, 2007
and incorporated herein by reference).                                                                                                                                                                                                                                                                                                                                             
|            | 
|3.2         |  | Bylaws of Platinum Research Organization, Inc. (filed as Exhibit B to the Companys Proxy Statement filed with the Securities and Exchange Commission on April 2, 2007 and incorporated
herein by reference).                                                                                                                                                                                                                                                                                                                                                                   
|            | 
|4.1         |  | Certificate of Designations for Series A Preferred Stock (incorporated by reference to Exhibit 4.1 to the Companys Current Report on Form 8-K dated April 18,
2007).                                                                                                                                                                                                                                                                                                                                                                                                         
|            | 
|4.2         |  | Registration Rights Agreement, dated April 18, 2007, between the Company, the investors named therein, Investa Corporation and Cecilia Pineda (incorporated by reference to Exhibit 4.4 filed with
the Companys Current Report on Form 8-K dated October 26, 2006).                                                                                                                                                                                                                                                                                                            
|            | 
|4.3         |  | Lock-Up Agreement, dated April 18, 2007, between the Company, Lubrication Partners, Joint Venture and Lubrication Partners, L.P. Pineda (incorporated by reference to Exhibit 4.7 filed with the
Companys Current Report on Form 8-K dated October 26, 2006).                                                                                                                                                                                                                                                                                                                  
|            | 
|4.4         |  | Voting Agreement, dated April 18, 2007, between the Company, Lubrication Partners, Joint Venture and Lubrication Partners, L.P. Pineda (incorporated by reference to Exhibit 4.6 filed with the
Companys Current Report on Form 8-K dated October 26, 2006).                                                                                                                                                                                                                                                                                                                   
|            | 
|10.1        |  | Consulting Agreement, dated April 14, 2007, between Platinum Research Organization, Inc., The Fairmount Company and John T. Jaeger, Jr. (incorporated by reference to Exhibit 10.1 filed with the
Companys Quarterly Report on Form 10-QSB for the period ended March 31, 2007).                                                                                                                                                                                                                                                                                               
|            | 
|10.2        |  | Platinum Research Organization, Inc. Stock Incentive Plan (filed as Exhibit E to the Companys Proxy Statement filed with the Securities and Exchange Commission on April 2, 2007 and
incorporated herein by reference).                                                                                                                                                                                                                                                                                                                                                        
|            | 
|10.3*       |  | Form of Non-Qualified Stock Option Agreement under the Platinum Research Organization, Inc. Stock Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                               
|            | 
|10.4*       |  | Form of Directors Non-Qualified Stock Option Agreement under the Platinum Research Organization, Inc. Stock Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                    
|            | 
|31.1*       |  | Certificate of CEO as Required by Rule 13a-14(a)/15d-14.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
|            | 
|31.2*       |  | Certificate of CFO as Required by Rule 13a-14(a)/15d-14.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
|            | 
|32.1*       |  | Certificate of CEO and CFO as Required by Rule 13a-14(b) and Rule 15d-14(b) (17 CFR 240.15d-14(b)) and Section 1350 of Chapter 63 of Title 18 of the United States Code.                                                                                                                                                                                                                                                                                                                                                                                                        

---

|* | Filed herewith
|- | --------------



21